Prev Close | 27.68 |
Day Low/High | 26.52 / 29.28 |
52 Wk Low/High | 20.23 / 153.41 |
Prev Close | 27.68 |
Day Low/High | 26.52 / 29.28 |
52 Wk Low/High | 20.23 / 153.41 |
Exchange | NASDAQ |
Shares Outstanding | 36.46B |
Market Cap | 1.01B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Betting that the indexes can't continue to run higher makes sense, but...
Tesla rocketed higher in a move similar to the bubble days of 20 years ago.
The bulls are hoping that this dead cat bounce transitions into a V-shaped bounce.
I learned from Jim Cramer long ago to focus on what can go right if you want to ride the momentum of stocks.
Shares of Iovance Biotherapeutics and Reata Pharmaceuticals took it on the chin in the fourth quarter, but both companies seem ready to reward shareholders for their patience.
Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.
Remembering these 'rules of the road' is vital in this highly volatile space.
Here are two I think will bounce back before the end of the year.
Here's two 'rules of the road' when investing in this highly volatile space.
I continue to keep a 'shopping list' at the ready for the next dip in the market.
I continue to believe that biotech and biopharma stocks will outperform in 2018.
Buyers expect a dovish Fed and are still trying to put money to work.
If the market closes weak today, it will be marked with an exclamation point.